Skip to Main Navigation
Skip to Page Content

COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC and research information from NIH.

U.S. flag

An official website of the United States government

Dot gov

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/7158

Diallyl phthalate: Target Organs and Levels of Evidence for TR-242

Carcinogenesis Bioassay of Diallyl Phthalate (CASRN 131-17-9) in B6C3F1 Mice (Gavage Study)

Chemical (Study Title)
CASRN
Peer Review DateRoute/Exposure LevelsStudy Laboratory
Diallyl phthalate
131-17-9
06/16/1982Gavage
0,150,300 MG/KG/50 PER GROUP
Litton Bionetics, Inc.

Levels of Evidence

Male Mice: Equivocal
TypeOrgan/Tissue (Lesion)
Neoplastic Lesions
  • Forestomach: SQUAMOUS CELL PAPILLOMA 0/49 1/47 2/49
  • Hematopoietic System: LYMPHOMA 6/50 5/50 12/50
Non-Neoplastic Lesions
  • FORESTOMACH: INFLAMMATION, CHRONIC; HYPERPLASIA
Female Mice: Equivocal
TypeOrgan/Tissue (Lesion)
Neoplastic Lesions
  • Forestomach: SQUAMOUS CELL PAPILLOMA 0/48 1/47 2/49
Non-Neoplastic Lesions
  • FORESTOMACH: INFLAMMATION, CHRONIC; HYPERPLASIA